首页|非肿块型DCIS影像学特点与临床病理特征及分子分型的相关性分析

非肿块型DCIS影像学特点与临床病理特征及分子分型的相关性分析

扫码查看
目的:探讨非肿块型乳腺导管内原位癌(DCIS)影像学特点,并分析影像学特点与临床病理特征及分子分型关系。方法:选取2020 年6 月至 2021 年 6 月在我院接受手术治疗的 100 例非肿块型DCIS患者作为研究对象,进行超声影像分分型,分别为Ⅰ型 31 例,Ⅱ型 15 例、Ⅲ型 43 例及Ⅳ型 11例。免疫组化检测病理组织雌激素受体(ER)、孕激索受体(PR)、人类表皮生长因子受体 2(HER2)及Ki-67 阳性表达;按照St。Gallen标准对患者进行Luminal A型及Luminal B型分子分型。结果:Ⅰ型:导管出现增粗,行走迂曲且管腔内出现低回声;Ⅱ型:乳腺内呈现片状的低回声区域,边界模糊;Ⅲ型:乳腺内呈现片状的低回声区域,可见分布不匀的点状强回声;Ⅳ型:乳腺内腺体及导管分布混乱,结构扭曲;Ⅰ型、Ⅱ型、Ⅲ型及Ⅳ型非肿块型DCIS患者临床病理资料年龄、肿瘤直径、月经状态、病灶部分、临床症状均无统计学差异(P>0。05),随着超声分型级别的升高细胞核分级也随之升高(P<0。05);Ⅰ型、Ⅱ型患者HER2 阳性表达差异无统计学意义(P>0。05),与Ⅰ型相比,Ⅲ型及Ⅳ型的HER2 阳性表达升高(P<0。05);与Ⅱ型相比,Ⅲ型的HER2 阳性表达升高,但与Ⅳ型差异无统计学意义(P>0。05),Ⅲ型与Ⅳ型的HER2 阳性表达组间比较差异无统计学意义(P>0。05);与Ⅰ型相比,Ⅲ型患者Luminal A型、Luminal B型分型分布升高(P<0。05)),与Ⅰ型相比,Ⅳ型患者 Luminal B 型分型分布升高(P<0。05)),Luminal A型差异无统计学意义(P>0。05)。结论:非肿块型DCIS患者超声主要为钙化型,认为结构紊乱型患者细胞核分级较高,且HER2 阳性表达较多,Luminal A型占比降低,Luminal B型占比升高。
Correlation Analysis Between Imaging Features Clinicopathological Characteristics and Molecular Subtypes of Non-Mass Ductal Carcinoma In Situ(DCIS)
Objective:To investigate the relationship between the imaging features and the clinicopatho-logical characteristics of non-mass ductal carcinoma in situ(DCIS)and to analyze their correlation with mo-lecular subtypes.Methods:This study selected 100 patients with non-mass DCIS who underwent surgical treat-ment at our hospital from June 2020 to June 2021.The patients were classified into four types(Type Ⅰ:31 ca-ses,Type Ⅱ:15 cases,Type Ⅲ:43 cases,and Type Ⅳ:11 cases)based on ultrasound findings.Immunohisto-chemistry was used to evaluate the positive expression of estrogen receptor(ER),progesterone receptor(PR),human epidermal growth factor receptor 2(HER2),and Ki-67.Patients were categorized into Luminal A and Luminal B molecular subtypes according to the St.Gallen standard.Results:Type Ⅰ exhibited thickened and tortuous ducts with low echogenicity within the lumen.Type Ⅱ displayed patchy hypoechoic areas with in-distinct boundaries in the breast.Type Ⅱ showed lamellar hypoechoic areas with unevenly distributed punctate strong echoes in the breast.Type Ⅳ presented disordered glandular structures with distorted architecture.There were no statistically significant differences in age,tumor diameter,menstrual status,lesion location,and clinical symptoms among patients with Type Ⅰ,Type Ⅱ,Type Ⅲ,and Type Ⅳ non-mass DCIS(P>0.05).However,as the ultrasound classification level increased,nuclear grade also increased(P<0.05).There were no signifi-cant differences in the positive expression of ER,PR,Ki-67 levels among Type Ⅰ,Type Ⅱ,Type Ⅲ and TypeⅣ non-mass DCIS patients(P>0.05).But,there was a significant difference in HER2 positive expression be-tween Type Ⅰ and Type Ⅱ,with Types Ⅲ and Ⅳ showing a higher HER2 positive expression(P<0.05).There was no significant difference in HER2 positive expression between type Ⅰ and type Ⅱ patients(P>0.05).Compared to type Ⅰ,type Ⅲ and type Ⅳ showed higher HER2 positive expression(P<0.05).Type Ⅲ had higher HER2 positive expression compared to type Ⅱ,but the difference with type Ⅳ was not statistically significant(P>0.05).The distribution of Luminal A and Luminal B subtypes increased in type Ⅲ compared to type Ⅰ(P<0.05),and the distribution of Luminal B subtype increased in type Ⅳ compared to type Ⅰ(P<0.05),while the difference in Luminal A subtype was not statistically significant(P>0.05).Conclusion:Pa-tients with non-mass DCIS mainly exhibited calcification on ultrasound.Patients with structural disorders had higher nuclear grades and more HER2 positive expression.These factors were correlated with a decrease in Lu-minal A subtype and an increase in Luminal B subtype.

Non-mass ductal carcinoma in situUltrasoundClassificationClinicopathology

刘芳、周梦红、王海娟、袁博、欧晓霞、李莉

展开 >

湖南中医药大学第一附属医院,湖南 长沙 410007

非肿块型乳腺导管内原位癌 超声 分级 临床病理

湖南省教育厅医学科学研究项目

21C0236

2024

河北医学
河北省医学会

河北医学

CSTPCD
影响因子:1.915
ISSN:1006-6233
年,卷(期):2024.30(1)
  • 8